ST上昇型急性心筋梗塞の診療に関するガイドライン(2013年改訂版)
Guidelines for the management of patients with ST-elevation acute myocardial infarction
(JCS 2013)
 

文献

801. Vona M, Codeluppi GM, Iannino T, et al. Effects of different types of exercise training followed by detraining on endotheliumdependent dilation in
        patients with recent myocardial infarction. Circulation 2009; 119: 1601-1608.
802. Ruygrok PN, Melkert R, Morel MA, et al. Does angiography six months after coronary intervention influence management and outcome? Benestent II
        Investigators. J Am Coll Cardiol 1999; 34: 1507-1511.
803. Shimada K, Kasanuki H, Hagiwara N, et al. Routine coronary angiographic follow-up and subsequent revascularization in patients with acute
        myocardial infarction. Heart Vessels 2008; 23: 383-389.
804. Deleted in proof.
805. 循環器病の診断と治療に関するガイドライン.心疾患患者の学校,職域,スポーツにおける運動許容条件に関するガイドライ ン(2008年改訂版).
        http://www.j-circ.or.jp/guideline/pdf/JCS2008_nagashima_h.pdf(2012年12月閲覧)
806. Pasternak RC. Comprehensive rehabilitation of patients with cardiovascular disease. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds.
        Braunwald's heart disease: a textbook of cardiovascular medicine, 7th edn. Elsevier Saunders, 2005; 1085-1102.
807. Gibbons RJ, Balady GJ, Bricker JT, et al: ACC/AHA 2002 guideline update for exercise testing: a report of the American College of
        Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). http://www. acc.org/clinical/guidelines/
        exercise/dirIndex.htm
808. Froom P, Cohen C, Rashcupkin J, et al. Referral to occupational medicine clinics and resumption of employment after myocardial infarction. J Occup
        Environ Med 1999; 41: 943-947.
809. Boudrez H, De Backer G. Recent findings on return to work after an acute myocardial infarction or coronary artery bypass grafting. Acta Cardiol 2000;
        55: 341-349.
810. Mittag O, Kolenda KD, Nordman KJ, et al. Return to work after myocardial infarction/coronary artery bypass grafting: patients' and physicians' initial
        viewpoints and outcome 12 months later. Soc Sci Med 2001; 52: 1441-1450.
811. Petrie KJ, Cameron LD, Ellis CJ, et al. Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial.
        Psychosom Med 2002; 64: 580-586.
812. Brodie B, Grines CL, Spain M, et al. 901-1 A prospective, randomized trial evaluating early discharge (day 3) without non-invasive risk stratification
        in low risk patients with acute myocardial infarction: PAMI-2. J Am Coll Cardiol 1995; 25: 5A.
813. ENRICHD Investigators. Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. Psychosom Med 2001;
        63: 747-755.
814. Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J
        Cardiol 2001; 88: 337-341.
815. Swenson JR, O'Connor CM, Barton D, et al; Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group.. Influence of depression
        and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol 2003; 92: 1271-1276.
816. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction:
        the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289: 3106-3116.
817. Case RB, Moss AJ, Case N, et al. Living alone after myocardial infarction. Impact on prognosis. JAMA 1992; 267: 515-519.
818. McCartney N. Role of resistance training in heart disease. Med Sci Sports Exerc 1998; 30: S396-402.
819. Miller NH, Taylor CB. Education, communication, and methods of intervention. In: Miller NH, Taylor CB. Lifestyle Management for Patients with
        Coronary Heart Disease (Current Issues in Cardiac Rehabilitation, Monograph no. 2). Human Kinetics 1995: 21-30.
820. Linden W. Psychological treatments in cardiac rehabilitation: review of rationales and outcomes. J Psychosom Res 2000; 48: 443-454.
821. Crowe JM, Runions J, Ebbesen LS, et al. Anxiety and depression after acute myocardial infarction. Heart Lung 1996; 25: 98-107.
822. Izawa KP, Watanabe S, Oka K, et al. Age-related differences in physiologic and psychosocial outcomes after cardiac rehabilitation.
        Am J Phys Med Rehabil 2010; 89: 24-33.
823. 第5次医療法改正.http://www.monju-jp.com/pub/iryouhoukaisei0703.html(2012年12月閲覧)
824. 田城孝雄.竹田綜合病院におけるプロトタイプ循環器連携パス.治療 2008; 90: 944-953.
825. 石木良治.トヨタ記念病院の循環器連携体制.治療 2008; 90: 954-960.
826. 町田陽二,東條美奈子,和泉徹,他.北里大学東病院心臓二次予防センターでの試み―増悪・再発予防.治療 2008; 90: 961-967.
827. 平松義博,野田喜寛,後藤葉一,他.心臓リハビリテーション パネルディスカッション 地域連携の現状と課題(まとめ).心臓リハ 2011; 16: 81-84.
828. 循環器病の診断と治療に関するガイドライン.循環器疾患における抗凝固・抗血小板療法に関するガイドライン(2009年改訂版).
        http://www.j-circ.or.jp/guideline/pdf/JCS2009_hori_h.pdf(2012年12月閲覧)
829. Kandzari DE, Angiolillo DJ, Price MJ, et al. Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization.
        JACC Cardiovasc Interv 2009; 2: 1279-1285.
830. Harjai KJ, Shenoy C, Orshaw P, et al. Dual antiplatelet therapy for more than 12 months after percutaneous coronary intervention: insights from the
        Guthrie PCI Registry. Heart 2009; 95: 1579-1586.
831. Park SJ, Park DW, Kim YH, et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med 2010; 362: 1374-1382.
832. Smith SC, Feldman TE, Hirshfeld JW, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention ―summary article: a
        report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to
        Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113: 156-175.
833. Pinto Slottow TL, Waksman R. Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent
        thrombosis. Catheter Cardiovasc Interv 2007; 69: 1064-1074.
834. Tada T, Natsuaki M, Morimoto T, et al. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent
        implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Circ Cardiovasc Interv 2012; 5: 381-391.
835. Ray WA, Murray KT, Griffin MR, et al. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med
        2010; 152: 337-345.
836. Douglas IJ, Evans SJ, Hingorani AD, et al. Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person
        study designs. BMJ 2012; 345: e4388.
837. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
838. Phrommintikul A, Kuanprasert S, Wongcharoen W, et al. Influenza vaccination reduces cardiovascular events in patients with acute coronary
        syndrome. Eur Heart J 2011; 32: 1730-1735.
839. Johnstone J, Loeb M, Teo KK, et al. Influenza vaccination and major adverse vascular events in high-risk patients. Circulation 2012; 126: 278-286.
840. Tseng HF, Slezak JM, Quinn VP, et al. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA 2010; 303: 1699-
        1706.
841. Granger CB, Henry TD, Bates WE, et al. Development of systems of care for ST-elevation myocardial infarction patients: the primary percutaneous
        coronary intervention (ST-elevation myocardial infarction-receiving) hospital perspective. Circulation 2007; 116: e55-59.
842. Williams SC, Schmaltz SP, Morton DJ, et al. Quality of care in U.S. hospitals as reflected by standardized measures, 2002-2004. N Engl J Med
        2005; 353: 255-264.
843. Krumholz HM, Anderson JL, Brooks NH, et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-STelevation myocardial
        infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to
        Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2006; 47: 236-265.
844. Roe MT, Parsons LS, Pollack CV, et al. National Registry of Myocardial Infarction Investigators. Quality of care by classification of myocardial
        infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction. Arch Intern Med 2005; 165: 1630-1636.
845. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent
        ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment
        elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999-3054.
846. Kushner FG, Hand M, Smith SC, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial
        infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the
        2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on
        Practice Guidelines. J Am Coll Cardiol 2009; 54: 2205-2241.
847. Hannan EL, Wu C, Walford G, et al. Volume-outcome relationships for percutaneous coronary interventions in the stent era. Circulation 2005; 112:
        1171-1179.
848. Post PN, Kuijpers M, Ebels T, et al. The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis. Eur
        Heart J 2010; 31: 1985-1992.
849. Wijns W, Kolh PH. Experience with revascularization procedures does matter: low volume means worse outcome. Eur Heart J 2010; 31: 1954-1957.
850.( 一般社団法人)日本心血管インターベンション治療学会ホームページ. http://www.cvit.jp/registry/(2012年12月閲覧)
851. Kumbhani DJ, Cannon CP, Fonarow GC, et al. Get With the Guidelines Steering Committee and Investigators. Association of hospital primary
        angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. JAMA 2009; 302: 2207-2213.
852. 東海林哲郎.心疾患に対する救急医療に関する診療の手引き,厚生省循環器病研究委託費9指―2.市民への啓蒙―急性心筋梗塞発症早期受診の重要性
        (野々木宏,編).2000: 98-103.
853. Faxon D, Lenfant C. Timing is everything: motivating patients to call 9-1-1 at onset of acute myocardial infarction. Circulation 2001; 104: 1210-1211.
854. 笠貫宏,高山守正.急性冠症候群患者の安定化.AHA心肺蘇生と救急心血管治療のためのガイドライン2005(日本語版). Japan Resuscitation Council and
        American Heart Association 2006: 118-142.
855. 日本版救急蘇生ガイドライン策定小委員会.救急蘇生法の指針─市民用.へるす出版 2006.
856. 急性心筋梗塞(ST上昇型)の診療に関するガイドライン.Circ J 2008; 72, Suppl. IV: 1347-1442.
857. 笠貫宏(班長).(2007-2008年度合同研究班報告) I.2. 循環器救急の現況と課題.循環器医のための心肺蘇生・心血管救急に関するガイドライン.Circ J
        2009; 73, Suppl. III: 1364-1366.
858. Nallamothu BK, Krumholz HM, Peterson ED, et al. D2B Alliance and the American Heart Association Get-With-The-Guidelines Investigators. Door-to-
        balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-toballoon (D2B) Alliance. Am J Cardiol 2009; 103: 1051-
        1055.
859. Heidenreich PA, Lewis WR, LaBresh KA, et al. Hospital performance recognition with the Get With The Guidelines Program and mortality for acute
        myocardial infarction and heart failure. Am Heart J 2009; 158: 546-553
 
 
目次へ